US$ 21.43
retatrutide phase 2 trial obesity nejm 2023 in adults with over 104 weeks in the highest dose group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Retatrutide UK: How It Works,
Description
Participants ranged in age from 18 to 70 years, with females surpassing males in most trials

Eur Med J (2015) 3(1):5765

Defer, G

Comparing intranasal retatrutide to other nasal peptides Intranasal retatrutide is not the first peptide to be explored through nasal delivery
Hashimoto's thyroiditis is an autoimmune condition causing hypothyroidism, treated with levothyroxine replacement therapy according to NICE guidance